A Necessary and Sufficient Determinant for Protein-selective Glycosylation in Vivo

Erin Miller, Dorothy Fiete, Nicquet M.J. Blake, Mary C. Beranek, Edward L. Oates, Yiling Mi, Daniel S. Roseman, Jacques Baenziger

Journal of Biological Chemistry · 2007 · 31 citations · 40 references

DOIFull text

Open access

Concepts

Abstract

A limited number of glycoproteins including luteinizing hormone and carbonic anhydrase-VI (CA6) bear N-linked oligosaccharides that are modified with β1,4-linked N-acetylgalactosamine (GalNAc). The selective addition of GalNAc to these glycoproteins requires that the β1,4-N-acetylgalactosaminyltransferase (βGT) recognize both the oligosaccharide acceptor and a peptide recognition determinant on the substrate glycoprotein. We report here that two recently cloned βGTs, βGT3 and βGT4, that are able to transfer GalNAc to GlcNAc in β1,4-linkage display the necessary glycoprotein specificity in vivo. Both βGTs transfer GalNAc to N-linked oligosaccharides on the luteinizing hormone α subunit and CA6 but not to those on transferrin (Trf). A single peptide recognition determinant encoded in the carboxyl-terminal 19-amino acid sequence of bovine CA6 mediates transfer of GalNAc to each of its two N-linked oligosaccharides. The addition of this 19-amino acid sequence to the carboxyl terminus of Trf confers full acceptor activity onto Trf for both βGT3 and βGT4 in vivo. The complete 19-amino acid sequence is required for optimal GalNAc addition in vivo, indicating that the peptide sequence is both necessary and sufficient for recognition by βGT3 and βGT4. A limited number of glycoproteins including luteinizing hormone and carbonic anhydrase-VI (CA6) bear N-linked oligosaccharides that are modified with β1,4-linked N-acetylgalactosamine (GalNAc). The selective addition of GalNAc to these glycoproteins requires that the β1,4-N-acetylgalactosaminyltransferase (βGT) recognize both the oligosaccharide acceptor and a peptide recognition determinant on the substrate glycoprotein. We report here that two recently cloned βGTs, βGT3 and βGT4, that are able to transfer GalNAc to GlcNAc in β1,4-linkage display the necessary glycoprotein specificity in vivo. Both βGTs transfer GalNAc to N-linked oligosaccharides on the luteinizing hormone α subunit and CA6 but not to those on transferrin (Trf). A single peptide recognition determinant encoded in the carboxyl-terminal 19-amino acid sequence of bovine CA6 mediates transfer of GalNAc to each of its two N-linked oligosaccharides. The addition of this 19-amino acid sequence to the carboxyl terminus of Trf confers full acceptor activity onto Trf for both βGT3 and βGT4 in vivo. The complete 19-amino acid sequence is required for optimal GalNAc addition in vivo, indicating that the peptide sequence is both necessary and sufficient for recognition by βGT3 and βGT4. Unique carbohydrate structures found on a number of glycoproteins are believed to contribute to biological functions ranging from transport of lysosomal enzymes to lysosomes (1Ghosh P. Dahms N.M. Kornfeld S. Nat. Rev. Mol. Cell. Biol. 2003; 4: 202-212Crossref PubMed Scopus (764) Google Scholar, 2Kornfeld S. Biochem. Soc. Trans. 1990; 18: 367-374Crossref PubMed Scopus (142) Google Scholar), to regulation of circulatory half-life of hormones (3Manzella S.M. Hooper L.V. Baenziger J.U. J. Biol. Chem. 1996; 271: 12117-12120Abstract Full Text Full Text PDF PubMed Scopus (86) Google Scholar, 4Hooper L.V. Manzella S.M. Baenziger J.U. FASEB J. 1996; 10: 1137-1146Crossref PubMed Scopus (83) Google Scholar), to cellular recognition (5Haltiwanger R.S. Lowe J.B. Annu. Rev. Biochem. 2004; 73: 491-537Crossref PubMed Scopus (635) Google Scholar, 6Lowe J.B. Marth J.D. Annu. Rev. Biochem. 2003; 72: 643-691Crossref PubMed Scopus (521) Google Scholar). The addition of unique carbohydrate structures to select glycoproteins requires a “recognition determinant,” a feature encoded in the peptide portion of these glycoproteins, to be recognized by one or more of the transferases responsible for their synthesis. In some cases key features of the peptide for such recognition determinants have been identified (7Mendiratta S.S. Sekulic N. Hernandez-Guzman F.G. Close B.E. Lavie A. Colley K.J. J. Biol. Chem. 2006; 281: 36052-36059Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar, 8Mendiratta S.S. Sekulic N. Lavie A. Colley K.J. J. Biol. Chem. 2005; 280: 32340-32348Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar, 9Nishikawa A. Nanda A. Gregory W. Frenz J. Kornfeld S. J. Biol. Chem. 1999; 274: 19309-19315Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar, 10Steet R. Lee W.S. Kornfeld S. J. Biol. Chem. 2005; 280: 33318-33323Abstract Full Text Full Text PDF PubMed Scopus (29) Google Scholar, 11Cuozzo J.W. Tao K. Cygler M. Mort J.S. Sahagian G.G. J. Biol. Chem. 1998; 273: 21067-21076Abstract Full Text Full Text PDF PubMed Scopus (52) Google Scholar). However, understanding the molecular basis for recognition ultimately requires that a recognition determinant that does not itself comprise the site of modification can be added to a structurally unrelated glycoprotein and confer selective modification of this unrelated glycoprotein. A limited number of glycoproteins bear N-linked or O-linked oligosaccharides that are modified with β1,4-linked GalNAc 4The abbreviations used are: GalNAcN-acetylgalactosamineβGTβ1,4-N-acetylgalactosaminyltransferaseCA6carbonic anhydrase-VITrftransferrinGLucGaussia luciferaseRLucRenilla luciferaseHEKhuman embryo kidneyCHOChinese hamster ovaryLHluteinizing hormoneWFAwisteria floribundia agglutininPBSphosphate-buffered salineBSAbovine serum albuminLUlight units. 4The abbreviations used are: GalNAcN-acetylgalactosamineβGTβ1,4-N-acetylgalactosaminyltransferaseCA6carbonic anhydrase-VITrftransferrinGLucGaussia luciferaseRLucRenilla luciferaseHEKhuman embryo kidneyCHOChinese hamster ovaryLHluteinizing hormoneWFAwisteria floribundia agglutininPBSphosphate-buffered salineBSAbovine serum albuminLUlight units. rather than β1,4-linked Gal. We first described such structures on the pituitary glycoprotein hormone LH, where it is further modified with sulfate to form terminal β1,4-linked GalNAc-4-SO4 (12Green E.D. Van Halbeek H. Boime I. Baenziger J.U. J. Biol. Chem. 1985; 260: 15623-15630Abstract Full Text PDF PubMed Google Scholar). We have recently shown that these sulfated structures contribute to regulation of the level of steroid hormone produced because they determine the circulatory half-life and thereby the circulating levels of LH in vivo (13Mi Y.-L. Shapiro S.D. Baenziger J.U. J. Clin. Investig. 2002; 109: 269-276Crossref PubMed Scopus (59) Google Scholar, 14Baenziger J.U. Kumar S. Brodbeck R.M. Smith P.L. Beranek M.C. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 334-338Crossref PubMed Scopus (159) Google Scholar, 15Fiete D. Srivastava V. Hindsgaul O. Baenziger J.U. Cell. 1991; 67: 1103-1110Abstract Full Text PDF PubMed Scopus (262) Google Scholar). 5Y. Mi, D. Fiete, and J. U. Baenziger, submitted for publication. 5Y. Mi, D. Fiete, and J. U. Baenziger, submitted for publication. Other glycoproteins that have different functions in vivo such as carbonic anhydrase-VI (CA6) (16Hooper L.V. Beranek M.C. Manzella S.M. Baenziger J.U. J. Biol. Chem. 1995; 270: 5985-5993Abstract Full Text Full Text PDF PubMed Scopus (48) Google Scholar), glycodelin (17Dell A. Morris H.R. Easton R.L. Panico M. Patankar M. Oehniger S. Koistinen R. Koistinen H. Seppala M. Clark G.F. J. Biol. Chem. 1995; 270: 24116-24126Abstract Full Text Full Text PDF PubMed Scopus (252) Google Scholar), prolactin-like proteins (18Manzella S.M. Dharmesh S.M. Cohick C.B. Soares M.J. Baenziger J.U. J. Biol. Chem. 1997; 272: 4775-4782Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar), proopiomelanocortin (19Skelton T.P. Kumar S. Smith P.L. Beranek M.C. Baenziger J.U. J. Biol. Chem. 1992; 267: 12998-13006Abstract Full Text PDF PubMed Google Scholar), SorLA/LR11 (20Fiete D. Mi Y. Oats E.L. Beranek M.C. Baenziger J.U. J. Biol. Chem. 2007; 282: 1873-1881Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar), sialoadhesin (21Martinez-Pomares L. Crocker P.R. Da Silva R. Holmes N. Colominas C. Rudd P. Dwek R. Gordon S. J. Biol. Chem. 1999; 274: 35211-35218Abstract Full Text Full Text PDF PubMed Scopus (88) Google Scholar), and tenascin-R (22Woodworth A. Fiete D. Baenziger J.U. Glycobiology. 2001; 11 (abstr. 45)Google Scholar) are also modified with β1,4-linked GalNAc. N-acetylgalactosamine β1,4-N-acetylgalactosaminyltransferase carbonic anhydrase-VI transferrin Gaussia luciferase Renilla luciferase human embryo kidney Chinese hamster ovary luteinizing hormone wisteria floribundia agglutinin phosphate-buffered saline bovine serum albumin light units. N-acetylgalactosamine β1,4-N-acetylgalactosaminyltransferase carbonic anhydrase-VI transferrin Gaussia luciferase Renilla luciferase human embryo kidney Chinese hamster ovary luteinizing hormone wisteria floribundia agglutinin phosphate-buffered saline bovine serum albumin light units. In in vitro studies we demonstrated that one or more βGTs present in the pituitary (23Smith P.L. Baenziger J.U. Science. 1988; 242: 930-933Crossref PubMed Scopus (96) Google Scholar) and other tissues (24Dharmesh S.M. Skelton T.P. Baenziger J.U. J. Biol. Chem. 1993; 268: 17096-17102Abstract Full Text PDF PubMed Google Scholar) are protein-specific, adding GalNAc to oligosaccharide acceptors on proteins that contain a peptide recognition determinant. The catalytic efficiency for this addition is 500-fold higher than for GalNAc transfer to the same oligosaccharide acceptors on proteins lacking the determinant in their peptide sequence (23Smith P.L. Baenziger J.U. Science. 1988; 242: 930-933Crossref PubMed Scopus (96) Google Scholar, 25Smith P.L. Baenziger J.U. Proc. Natl. Acad. Sci. U. S. A. 1990; 87: 7275-7279Crossref PubMed Scopus (38) Google Scholar). We reported that the basic amino acids within the sequence PLRSKK that is present in the pituitary glycoprotein hormone α subunit are critical elements of the peptide recognition determinant conferring transfer of GalNAc to N-linked oligosaccharides in vitro (26Mengeling B.J. Manzella S.M. Baenziger J.U. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 502-506Crossref PubMed Scopus (68) Google Scholar, 27Smith P.L. Baenziger J.U. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 329-333Crossref PubMed Scopus (108) Google Scholar). Two recently cloned βGTs, βGT3 (28Sato T. Gotoh M. Kiyohara K. Kameyama A. Kubota T. Kikuchi N. Ishizuka Y. Iwasaki H. Togayachi A. Kudo T. Ohkura T. Nakanishi H. Narimatsu H. J. Biol. Chem. 2003; 278: 47534-47544Abstract Full Text Full Text PDF PubMed Scopus (75) Google Scholar, 29Ikehara Y. Sato T. Niwa T. Nakamura S. Gotoh M. Ikehara S.K. Kiyohara K. Aoki C. Iwai T. Nakanishi H. Hirabayashi J. Tatematsu M. Narimatsu H. Glycobiology. 2006; 16: 777-785Crossref PubMed Scopus (39) Google Scholar), and βGT4 (30Gotoh M. Sato T. Kiyohara K. Kameyama A. Kikuchi N. Kwon Y.D. Ishizuka Y. Iwai T. Nakanishi H. Narimatsu H. FEBS Lett. 2004; 562: 134-140Crossref PubMed Scopus (50) Google Scholar) that are closely related transfer GalNAc in β1,4-linkage to terminal GlcNAc. They are expressed in tissues that have previously been determined to express protein-specific GalNAc transferase activity, but they have not yet themselves been shown to be protein-specific either in vitro or in vivo. We now report the development of unique chimeric glycoprotein constructs that allow us to examine the efficiency of GalNAc addition to N-linked carbohydrates on these glycoproteins in the complex milieu of the Golgi. The chimeric proteins consist of either Renilla (31Lorenz W.W. Cormier M.J. O'Kane D.J. Hua D. Escher A.A. Szalay A.A. J. Biolumin. Chemilumin. 1996; 11: 31-37Crossref PubMed Scopus (67) Google Scholar, 32Liu J. O'Kane D.J. Escher A. Gene (Amst.). 1997; 203: 141-148Crossref PubMed Scopus (43) Google Scholar, 33Liu J. Escher A. Gene (Amst.). 1999; 237: PubMed Scopus Google Scholar) or Gaussia M. Chem. 2002; PubMed Scopus Google Scholar, R. Mol. 2005; 11: Full Text Full Text PDF PubMed Scopus Google Scholar) luciferase and glycoproteins that or not bear N-linked oligosaccharides modified with β1,4-linked GalNAc. these chimeric glycoproteins in that express either βGT3 or βGT4, we able to their of modification with β1,4-linked GalNAc in vivo. this we that βGT3 and βGT4 are protein-specific, a peptide determinant in the substrate to allow and transfer of GalNAc to their oligosaccharides. We have identified a 19-amino acid sequence that is both necessary and sufficient to protein-specific GalNAc addition by βGT3 and βGT4. The addition of this sequence to a glycoprotein that is not recognized by either βGT3 or βGT4 the glycoprotein one that is modified with β1,4-linked GalNAc in vivo. of the Renilla luciferase J. O'Kane D.J. Escher A. Gene (Amst.). 1997; 203: 141-148Crossref PubMed Scopus (43) Google Scholar, 33Liu J. Escher A. Gene (Amst.). 1999; 237: PubMed Scopus Google Scholar) and and the Gaussia luciferase M. Chem. 2002; PubMed Scopus Google Scholar, R. Mol. 2005; 11: Full Text Full Text PDF PubMed Scopus Google Scholar) and be described in from with a to The chimeric glycoproteins and consist of the glycoprotein hormone α subunit or Trf by its carboxyl terminus with and the and consist of the sequence by and CA6 or α their carboxyl with from The constructs in each consist of by or CA6 and the is a is and the of and CA6 from the of the and S. C. R. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar, Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar). The sequence amino acids from CA6 added to Trf and as described A Scholar). A of the key luciferase including the of the and the amino acid that the recognition is shown in in of βGT3 or βGT4 of the and as described M. J. Y. Mi, L. M. and J. U. Baenziger, submitted for publication. and in bovine in of phosphate-buffered saline and of in of added to the The and The in for GalNAc to with by adding of of and for The with bovine serum albumin a of with the with of and by for with of with of luciferase light of luciferase activity in of with the for in the or of GalNAc. The with and of added to each The of luciferase activity a by of luciferase each and the produced a of The by the in of GalNAc from the in the of GalNAc. The in each than and from the of GalNAc to a form of carbonic N-linked oligosaccharides that are modified with β1,4-linked GalNAc it is expressed by or (16Hooper L.V. Beranek M.C. Manzella S.M. Baenziger J.U. J. Biol. Chem. 1995; 270: 5985-5993Abstract Full Text Full Text PDF PubMed Scopus (48) Google Scholar). We have previously shown that express protein-specific βGTs that are able to the N-linked oligosaccharides on LH and other glycoproteins with β1,4-linked GalNAc (20Fiete D. Mi Y. Oats E.L. Beranek M.C. Baenziger J.U. J. Biol. Chem. 2007; 282: 1873-1881Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar, S.M. Skelton T.P. Baenziger J.U. J. Biol. Chem. 1993; 268: 17096-17102Abstract Full Text PDF PubMed Google Scholar, A. P. Fiete D. Baenziger J.U. J. Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, P.L. Skelton T.P. Fiete D. Dharmesh S.M. Beranek M.C. L. Baenziger J.U. J. Biol. Chem. 1992; 267: Full Text PDF PubMed Google Scholar, P.L. D. J. Baenziger J.U. J. Biol. Chem. 1990; Full Text PDF PubMed Google Scholar). with its carboxyl terminus is expressed in of the is by a that oligosaccharides terminal β1,4-linked GalNAc B.J. Smith P.L. Smith Baenziger J.U. Biochem. 1991; PubMed Scopus Google Scholar, Smith Biochem. 1988; PubMed Scopus Google Scholar) the β1,4-linked GalNAc added to N-linked oligosaccharides on glycoproteins expressed by can be further modified with either or in the The of is with GalNAc The by in the of with GalNAc because expressed in does not contain GalNAc and is not by the N-linked oligosaccharides on expressed in are modified with β1,4-linked the glycoprotein hormone α a recognition determinant that in its selective modification with GalNAc expressed by The 19-amino acid sequence the carboxyl terminus of bovine CA6 basic amino acids in such as that of and Annu. Rev. Biochem. PubMed Scopus Google Scholar) that this sequence is to form α of CA6 the PLRSKK sequence of the glycoprotein hormone α subunit that α in the form of the hormone H. J.W. Y. Full Text Full Text PDF PubMed Scopus Google Scholar, A. J.W. K.J. PubMed Scopus Google Scholar) and is for recognition by pituitary in in vitro (26Mengeling B.J. Manzella S.M. Baenziger J.U. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 502-506Crossref PubMed Scopus (68) Google Scholar). The sequence from the carboxyl-terminal 19-amino acid sequence of CA6 in In to than of the produced by is by and from the by GalNAc. is by CA6 a recognition determinant that is by the expressed by and the sequence is a critical of this recognition the of in for of the of a glycoprotein that is modified with terminal β1,4-linked GalNAc expressed in different is We chimeric glycoproteins that consist of either or and the glycoprotein of The consist of the glycoprotein by the carboxyl terminus by the and are the of and The of GalNAc addition to each of these luciferase can be by onto onto the and the of luciferase activity that been and a single of either βGT3 or βGT4 the of luciferase activity expressed as of for than for both and of the site to to the PLRSKK sequence that we previously determined is for recognition in vitro (26Mengeling B.J. Manzella S.M. Baenziger J.U. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 502-506Crossref PubMed Scopus (68) Google Scholar) GalNAc addition to In of the site more from the PLRSKK sequence to but does not GalNAc addition to is modified by both βGT3 and βGT4 in vivo, is not modified by either The of and with in vitro studies the α subunit a peptide sequence that is recognized by and as a is modified with a catalytic efficiency that is 500-fold than for glycoproteins that not contain a recognition determinant for the (23Smith P.L. Baenziger J.U. Science. 1988; 242: 930-933Crossref PubMed Scopus (96) Google Scholar, 25Smith P.L. Baenziger J.U. Proc. Natl. Acad. Sci. U. S. A. 1990; 87: 7275-7279Crossref PubMed Scopus (38) Google Scholar, B.J. Manzella S.M. Baenziger J.U. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 502-506Crossref PubMed Scopus (68) Google Scholar, 27Smith P.L. Baenziger J.U. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 329-333Crossref PubMed Scopus (108) Google Scholar). In the oligosaccharide added to to be the for GalNAc addition in the The expressed by either or is not by indicating GalNAc is not added to this the sequence that is for GalNAc addition to is the carboxyl we in the the α and CA6 is the and is modified with GalNAc expressed in either or indicating the of the is not critical for recognition of the α subunit by either βGT3 or βGT4 A and with A and In is modified with GalNAc it is expressed in either or A and the of the the carboxyl terminus of does not with recognition by either βGT3 or βGT4, the of the luciferase sequence the carboxyl terminus of CA6 is sufficient to with of the sequence from to GalNAc addition by βGT3 and by βGT4 of each site but does not GalNAc addition to either or of both GalNAc addition to The with that βGT3 and βGT4 the same recognition determinant in vivo and are able to transfer GalNAc to oligosaccharides two different on by βGT3 and βGT4 onto by from is a form of luciferase that is more than the of M. Chem. 2002; PubMed Scopus Google Scholar, R. Mol. 2005; 11: Full Text Full Text PDF PubMed Scopus Google Scholar). In each of the chimeric glycoprotein is the of for each of these constructs with light of luciferase activity present of The constructs shown in and with with the is modified with GalNAc it is expressed in either or is not modified with GalNAc. of the key basic in α from PLRSKK to GalNAc addition to by either βGT3 or βGT4 to the level for A and the carboxyl-terminal amino acids from CA6 to a form of that is modified to a than with GalNAc by both βGT3 and βGT4 A and The of GalNAc added to by βGT3 and βGT4 is and in the of the carboxyl-terminal 19-amino acid sequence from The addition of the carboxyl-terminal amino acids that contain the in GalNAc addition to by βGT3 and βGT4 and the sequence does not have the required for recognition by either βGT3 or βGT4. the first amino acids within the 19-amino acid sequence added to also contain basic we that does not contain the amino acids including the is modified with GalNAc expressed in and A and but not to the same as a the carboxyl-terminal amino acids of also and and is modified to than but not to the same as and the full 19-amino acid sequence from the carboxyl terminus of CA6 is to for optimal modification of N-linked oligosaccharides on Trf by βGT3 and βGT4 in vivo. studies and glycoprotein that βGT3 and βGT4 are in vivo. Both βGTs transfer GalNAc to N-linked oligosaccharides on the pituitary glycoprotein hormone α subunit and on CA6 but not to the oligosaccharide acceptors on glycoproteins such as the 19-amino acid sequence from the carboxyl terminus of CA6 to the carboxyl terminus of Trf a glycoprotein that is modified by βGT3 and by βGT4. is because Trf to either the α subunit or to The of human serum transferrin recently been J. C. S.K. J. Biol. Chem. 2006; 281: Full Text Full Text PDF PubMed Scopus Google Scholar). The two N-linked and are on of peptide and are both in to the carboxyl terminus of The addition of the recognition sequence to Trf to transfer of GalNAc to both N-linked oligosaccharides as it does in this 19-amino acid sequence is sufficient to confer recognition onto in vivo by both βGT3 and βGT4, it is that the same key to recognition by both because peptide recognition and GalNAc transfer to terminal GlcNAc the addition of this sequence to glycoprotein confer recognition by βGT3 and βGT4 and selective modification of N-linked oligosaccharides with β1,4-linked GalNAc in vivo. The N-linked oligosaccharide acceptor that is modified with β1,4-linked GalNAc on glycoproteins such as the glycoprotein hormone LH and CA6 is in to the N-linked oligosaccharide acceptors on glycoproteins that are not modified with GalNAc but are modified with β1,4-linked Gal. us to the of a peptide recognition determinant on glycoproteins that be modified with β1,4-linked We this by glycoproteins that and not contain a recognition determinant as acceptors for GalNAc addition in in vitro we have demonstrated that in vivo the same recognition determinant is by βGTs and that the of the recognition determinant is necessary for modification with β1,4-linked GalNAc. in vitro we identified the basic amino acids in the sequence PLRSKK that is found in the α subunit as for recognition by the activity present in the The of GalNAc transfer to by either βGT3 or βGT4 now the in vivo that the basic amino acids in the PLRSKK sequence are critical elements of the recognition determinant. the in GalNAc transfer by βGT3 and βGT4 to that the sequence that basic amino acids are critical elements of the recognition determinant in The with and that the basic amino acids within these are necessary for recognition in vivo. The of a glycoprotein that to glycoproteins to be modified with β1,4-linked a substrate for GalNAc addition by in vivo us for the first to a sequence that is sufficient to The addition of the carboxyl-terminal amino acids of to the carboxyl terminus of Trf in a glycoprotein that modified with GalNAc by both βGT3 and βGT4 to the same or a than in vivo. The 19-amino acid sequence is sufficient to confer recognition by βGT3 and βGT4 in vivo. and are also modified GalNAc in vivo but not to the same as the first the and the amino acids of this 19-amino acid sequence are able to confer some recognition by βGT3 and βGT4 in the full 19-amino acid sequence is more 19-amino acid sequence is sufficient for recognition in vivo by both βGT3 and βGT4, and the sequence is necessary to transfer of GalNAc in vivo. The of to confer as transfer of GalNAc to as that a of basic is not sufficient to A number of different for the of including Annu. Rev. Biochem. PubMed Scopus Google Scholar, of and the of Google Scholar), J. D.J. J. Mol. Biol. PubMed Scopus Google Scholar), C. C. C. Biochem. Sci. Full Text Full Text PDF PubMed Scopus Google Scholar), and each of the that this sequence α it is that the for the 19-amino acid sequence the to a that basic in the to with βGT3 and βGT4. The to confer recognition by both βGT3 and βGT4 onto by adding the carboxyl-terminal amino acids from CA6 that the key elements of this sequence that are recognized by these closely related transferases are not The that a single recognition determinant can to GalNAc addition to two N-linked oligosaccharides on CA6 and can confer recognition onto unrelated that the peptide recognition determinant does not with the oligosaccharide the peptide recognition determinant and the oligosaccharide acceptor with βGT3 and βGT4 βGT3 and βGT4 are of and amino The carboxyl-terminal of βGT3 and βGT4, of and amino are and contain that are of (28Sato T. Gotoh M. Kiyohara K. Kameyama A. Kubota T. Kikuchi N. Ishizuka Y. Iwasaki H. Togayachi A. Kudo T. Ohkura T. Nakanishi H. Narimatsu H. J. Biol. Chem. 2003; 278: 47534-47544Abstract Full Text Full Text PDF PubMed Scopus (75) Google Scholar, M. Sato T. Kiyohara K. Kameyama A. Kikuchi N. Kwon Y.D. Ishizuka Y. Iwai T. Nakanishi H. Narimatsu H. FEBS Lett. 2004; 562: 134-140Crossref PubMed Scopus (50) Google Scholar). is to the catalytic the that mediates peptide recognition the of the other of these transferases is the 19-amino acid sequence from the carboxyl terminus of CA6 is sufficient to recognition in vivo and in it is now to that allow us to the key features of this determinant that are required for optimal also be to the of βGT3 and βGT4 that the recognition determinant. The of glycoproteins N-linked structures β1,4-linked GalNAc is a in vivo, the of both the transferases and glycoproteins that have a recognition determinant. In the of the glycoprotein hormone LH, the of the N-linked a critical in in vivo and J.U. Kumar S. Brodbeck R.M. Smith P.L. Beranek M.C. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 334-338Crossref PubMed Scopus (159) Google Scholar, 15Fiete D. Srivastava V. Hindsgaul O. Baenziger J.U. Cell. 1991; 67: 1103-1110Abstract Full Text PDF PubMed Scopus (262) Google Scholar). with GalNAc are also present on other glycoproteins such as the SorLA/LR11 (20Fiete D. Mi Y. Oats E.L. Beranek M.C. Baenziger J.U. J. Biol. Chem. 2007; 282: 1873-1881Abstract Full Text Full Text PDF PubMed Scopus (26) Google Scholar) that been as a for development of Y. Lee Y. T. T. R. H. N. R. C. Y. L. I. S. A. R. R. W. H. N. D. S.D. S. R. P. Nat. 2007; PubMed Scopus Google Scholar) and in the (22Woodworth A. Fiete D. Baenziger J.U. Glycobiology. 2001; 11 (abstr. 45)Google Scholar). The and selective addition of GalNAc unique structures that a number of different in vivo. the key features of this 19-amino acid recognition determinant allow us to glycoproteins that also bear this unique The addition of β1,4-linked GalNAc is the of carbohydrate the selective addition of GalNAc is determined a for understanding regulation of the of carbohydrate structures to in vivo.

References

40